Concepedia
Statistics
Publications
5
Citations
193
H-Index
Active since
2017
Affiliations
Oncor (United States)(Current)
Polish Academy of Sciences
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy
Agnieszka Denslow is an author at Oncor (United States) specializing in oncology, oncolytic viral vectors, and molecular oncology.
Publications per year
2017–2022
ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity
Brian B. Haines, Agnieszka Denslow, Peter Grzesik et al. · Cancer Immunology Research · 2020 · 68 citations · Full text
Medicine, Immunology, Oncology +17
Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer
Edward M. Kennedy, Agnieszka Denslow, Jacqueline Hewett et al. · Nature Communications · 2022 · 41 citations · Full text
Life Sciences, Cancer Biology, Oncology +17
Clopidogrel in a combined therapy with anticancer drugs—effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models
Agnieszka Denslow, Marta Świtalska, Joanna Jarosz et al. · PLoS ONE · 2017 · 34 citations · Full text
Medicine, Oncology, Pharmacology +17
Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents
Kamil Hoffmann, Joanna Wı́sniewska, Andrzej Wojtczak et al. · Journal of Inorganic Biochemistry · 2017 · 25 citations
Pharmacy, Chemistry, Medicinal Chemistry +17
Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability
Edward M. Kennedy, Terry Farkaly, Peter Grzesik et al. · Molecular Therapy — Oncolytics · 2020 · 25 citations · Full text
Life Sciences, Infectious Diseases, Oncology +17
1–5 of 5